Advertisement

Topics

FDA approves treatment for rapidly progressing type of cancer

10:00 EDT 21 Aug 2017 | EPM Magazine

The US Food and Drug Administration (FDA) has approved a targeted therapy, Besponsa (inotuzumab ozogamicin), for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL).

Original Article: FDA approves treatment for rapidly progressing type of cancer

NEXT ARTICLE

More From BioPortfolio on "FDA approves treatment for rapidly progressing type of cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...